Introduction
Rabepar DSR Capsule by Astemax Biotech delivers rabeprazole gastro-resistant pellets alongside domperidone sustained-release pellets, providing extended relief from acid reflux and gastric issues. This advanced DSR formulation ensures optimal efficacy through prolonged action, manufactured in WHO-GMP certified facilities for superior quality and ethical promotion.
Capsule Essentials
Rabepar DSR combines rabeprazole 40 mg (gastro-resistant) and domperidone 30 mg (sustained-release) in a single daily capsule. The dual sustained-release technology protects rabeprazole from stomach acid while steadily releasing domperidone for consistent motility support. Perfect for managing chronic GERD symptoms effectively.
Core Advantages
-
Suppresses acid production rapidly while enhancing stomach emptying to combat heartburn and nausea.
-
Offers 24-hour symptom control, reducing bloating, regurgitation, and ulcer risks.
-
Boosts patient adherence with convenient once-daily dosing and minimal gastrointestinal upset.
Manufacturing Standards
Produced by Astemax Biotech in state-of-the-art WHO-GMP certified plants, Rabepar DSR guarantees purity, stability, and batch consistency. Ethical marketing highlights clinically proven benefits, fostering trust among healthcare professionals without exaggerated claims.
Action Mechanism
Rabeprazole potently inhibits proton pumps to slash acid secretion by up to 90%, complemented by domperidone’s prokinetic effects on gut motility. The DSR design ensures targeted intestinal release and sustained plasma levels for peak therapeutic efficiency.
Recommended Use
Swallow one capsule whole daily before meals with water, as advised by a physician. Not for prolonged self-use; monitor in liver conditions or pregnancy. Keep stored cool and dry.
